Literature DB >> 7645473

Portal vein thrombosis in patients with cirrhosis: does sonographic detection of intrathrombus flow allow differentiation of benign and malignant thrombus?

G D Dodd1, D S Memel, R L Baron, L Eichner, L A Santiguida.   

Abstract

OBJECTIVE: The objective of our study was to determine if the detection by Doppler sonography of blood flow in portal vein thrombi occurring in patients with cirrhosis could be used to distinguish benign from malignant portal vein thrombi. SUBJECTS AND METHODS: Color and duplex Doppler sonographic examinations were performed in 47 patients with proven cirrhosis and portal vein thrombi. The examinations were directed at the detection of continuous or pulsatile flow within the portal vein thrombi. The nature of the portal vein thrombi was proven histologically in 27 patients and by CT findings and clinical history in 20 patients. The frequency, type, and direction of portal vein thrombus flow was evaluated to determine if there was any correlation with the benign or malignant nature of the portal vein thrombi.
RESULTS: Of the 47 patients, 26 had malignant portal vein thrombi and 21 had benign portal vein thrombi. Blood flow was detected in 22 of the malignant and in 15 of the benign portal vein thrombi. The blood flow was pulsatile in 16 malignant and three benign portal vein thrombi and continuous in six malignant and 12 benign portal vein thrombi. The direction of the pulsatile flow in the malignant portal vein thrombi was predominantly (13/16) hepatofugal. All continuous flow in both benign and malignant portal vein thrombi was hepatopetal. The detection of pulsatile flow in portal vein thrombi yielded a 62% sensitivity and 95% specificity for the diagnosis of malignant portal vein thrombus.
CONCLUSION: The detection by Doppler sonography of pulsatile flow in portal vein thrombi occurring in patients with cirrhosis is a moderately sensitive but highly specific sign for the diagnosis of malignant portal vein thrombus. However, continuous flow can be detected in benign and malignant portal vein thrombus and is thus not useful in differentiating between the two.

Entities:  

Mesh:

Year:  1995        PMID: 7645473     DOI: 10.2214/ajr.165.3.7645473

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  20 in total

1.  Radiation therapy for portal venous invasion by hepatocellular carcinoma.

Authors:  Keiichi Nakagawa; Hideomi Yamashita; Kenshiro Shiraishi; Naoki Nakamura; Masao Tago; Hiroshi Igaki; Yoshio Hosoi; Shuichiro Shiina; Masao Omata; Masatoshi Makuuchi; Kuni Ohtomo
Journal:  World J Gastroenterol       Date:  2005-12-14       Impact factor: 5.742

Review 2.  Imaging in liver transplantation.

Authors:  Settimo Caruso; Roberto Miraglia; Luigi Maruzzelli; Salvatore Gruttadauria; Angelo Luca; Bruno Gridelli
Journal:  World J Gastroenterol       Date:  2009-02-14       Impact factor: 5.742

3.  Differentiation of neoplastic from bland macroscopic portal vein thrombi using dual-energy spectral CT imaging: a pilot study.

Authors:  Li Jun Qian; Jiong Zhu; Zhi Guo Zhuang; Qiang Xia; Yu Fan Cheng; Jian Ying Li; Jian Rong Xu
Journal:  Eur Radiol       Date:  2012-05-24       Impact factor: 5.315

4.  Tumor thrombus in the venous drainage pathways of primary, recurrent and metastatic disease on routine oncologic imaging studies: beyond hepatocellular and renal cell carcinomas.

Authors:  Sireesha Yedururi; HyunSeon Kang; Veronica L Cox; Sumedha Chawla; Ott Le; Evelyne M Loyer; Leonardo Marcal
Journal:  Br J Radiol       Date:  2019-04-24       Impact factor: 3.039

5.  Prediction of recurrence and prognosis in patients with hepatocellular carcinoma after resection by use of CLIP score.

Authors:  Wen-He Zhao; Zhi-Min Ma; Xing-Ren Zhou; Yi-Zheng Feng; Bao-Shan Fang
Journal:  World J Gastroenterol       Date:  2002-04       Impact factor: 5.742

6.  Contrast-enhanced ultrasonography and spiral computed tomography in the detection and characterization of portal vein thrombosis complicating hepatocellular carcinoma.

Authors:  Sandro Rossi; Giorgia Ghittoni; Valentina Ravetta; Francesca Torello Viera; Laura Rosa; Martina Serassi; Mara Scabini; Alessandro Vercelli; Carmine Tinelli; Barbara Dal Bello; Peter N Burns; Fabrizio Calliada
Journal:  Eur Radiol       Date:  2008-03-28       Impact factor: 5.315

7.  Cardiovascular involvement by osteosarcoma: an analysis of 20 patients.

Authors:  Sireesha Yedururi; Ajaykumar C Morani; Gregory W Gladish; Srilakshmi Vallabhaneni; Peter M Anderson; Dennis Hughes; Wei-Lien Wang; Najat C Daw
Journal:  Pediatr Radiol       Date:  2015-09-28

8.  Contrast-enhanced sonography versus biopsy for the differential diagnosis of thrombosis in hepatocellular carcinoma patients.

Authors:  Paolo Sorrentino; Salvatore D'Angelo; Luciano Tarantino; Umberto Ferbo; Alessandra Bracigliano; Raffaela Vecchione
Journal:  World J Gastroenterol       Date:  2009-05-14       Impact factor: 5.742

9.  Highly metabolic thrombus of the portal vein: 18F fluorodeoxyglucose positron emission tomography/computer tomography demonstration and clinical significance in hepatocellular carcinoma.

Authors:  Long Sun; Yong-Song Guan; Wei-Ming Pan; Gui-Bing Chen; Zuo-Ming Luo; Ji-Hong Wei; Hua Wu
Journal:  World J Gastroenterol       Date:  2008-02-28       Impact factor: 5.742

Review 10.  Hepatocellular carcinoma with obstructive jaundice: diagnosis, treatment and prognosis.

Authors:  Lun-Xiu Qin; Zhao-You Tang
Journal:  World J Gastroenterol       Date:  2003-03       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.